Nos publications scientifiques

Département d’Onco-Ophtalmologie Niçois
DOON > La recherche sur les cancers oculaires > Nos publications scientifiques

C’est à la qualité des publications scientifiques que l’on évalue le travail des chercheurs. Ces publications dans des revues internationales comme Nature, Nature Genetics, the Lancet, PLoS One, PLoS Medicine, Gut, the New England Journal of Medicine… sont le reflet de l’excellence de la production. La bibliométrie, incluant une évaluation quantitative des facteurs d’impact dans les revues prestigieuses, reflète l’intérêt de la communauté scientifique pour les découvertes qui sont ainsi reprises et citées.

La bibliométrie évalue l’activité de la recherche en appliquant des méthodes statistiques aux publications scientifiques (bibliographie des articles, signatures des articles, mots-clés et auteurs,…). Elle permet de mesurer la production scientifique et la notoriété d’un chercheur, d’un laboratoire, d’un établissement, d’un pays, d’un domaine de recherche…

Nos publications

2022

  • Thariat J, Martel A, Matet A, Loria O, Kodjikian L, Nguyen AM, Rosier L, Herault J, Nahon-Estève S, Mathis T. Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit. Cancers. 2022;14(5):1194. doi:10.3390/cancers14051194
  • Saint-Ghislain M, Derrien AC, Geoffrois L, Gastaud L, Lesimple T, Negrier S, Penel N, Kurtz JE, Le Corre Y, Dutriaux C, Gardrat S, Barnhill R, Matet A, Cassoux N, Houy A, Ramtohul T, Servois V, Mariani P, Piperno-Neumann S, Stern MH, Rodrigues M. MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients. Eur J Cancer Oxf Engl 1990. 2022;173:105-112. doi:10.1016/j.ejca.2022.06.033
  • Michallet M, Sobh M, Morisset S, Deloire A, Raffoux E, de Botton S, Caillot D, Chantepie S, Girault S, Berthon C, Bertoli S, Lepretre S, Leguay T, Castaigne S, Marolleau JP, Pautas C, Malfuson JV, Veyn N, Braun T, Gastaud L, Suarez F, Schmidt A, Gressin R, Bonmati C, Celli-Lebras K, El-Hamri M, Ribaud P, Dombret H, Thomas X, Bergeron A. Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group. Clin Lymphoma Myeloma Leuk. 2022;22(5):311-318. doi:10.1016/j.clml.2021.10.011
  • Matonti F, Korobelnik JF, Dot C, Gualino V, Soler V, Mrejen S, Delyfer MN, Baillif S, Streho M, Gascon P, Creuzot-Garcher C, Kodjikian L. Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis. J Clin Med. 2022;11(7):1834. doi:10.3390/jcm11071834
  • Martini K, Schaub S, Bertoloto C, Baillif S, Lassalle S, Martel P, Martel A. What Is the Best Candidate to Replace the Tarsus? A Biomechanical, Histological, and Optical Study Comparing Five Grafts. Transl Vis Sci Technol. 2022;11(12):6. doi:10.1167/tvst.11.12.6
  • Martel A, Baillif S, Thomas P, Almairac F, Galatoire O, Hamedani M, Fontaine D, Lanteri-Minet M. Phantom vision after eye removal: prevalence, features and related risk factors. Br J Ophthalmol. 2022;106(11):1603-1609. doi:10.1136/bjophthalmol-2021-319091
  • Marmouset V, Decroocq J, Garciaz S, Etienne G, Belhabri A, Bertoli S, Gastaud L, Simand C, Chantepie S, Uzunov M, Genthon A, Berthon C, Chiche E, Dumas PY, Vargaftig J, Salmeron G, Lemasle E, Tavernier E, Delage J, Loirat M, Morineau N, Blanc-Durand F, Pautier P, Vergé V, Auger N, Thomas M, Stefani L, Lepelley M, Boyer T, Thepot S, Gourin MP, Bourquard P, Duchmann M, Morice PM, Michallet M, Adès L, Fenaux P, Récher C, Dombret H, Pagès A, Marzac C, Leary A, Micol JB, UNIHEM, French Network of Pharmacovigilance Centers, ALFA, FILO, and GFM. Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience. Clin Cancer Res Off J Am Assoc Cancer Res. 2022;28(23):5211-5220. doi:10.1158/1078-0432.CCR-22-1622
  • Marin L, Toumi E, Caujolle JP, Doyen J, Martel A, Nahon-Esteve S, Maschi C, Baillif S. OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study. Eur J Ophthalmol. 2022;32(5):3035-3042. doi:10.1177/11206721211067331
  • Long-Mira E, Picard-Gauci A, Lassalle S, Hofman V, Lalvée S, Tanga V, Zahaf K, Bonnetaud C, Lespinet V, Camuzard O, Montaudié H, Poissonnet G, Passeron T, Ilié M, Hofman P. Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes. Diagn Basel Switz. 2022;12(3):751. doi:10.3390/diagnostics12030751
  • Lebrize S, Arnould L, Bourredjem A, Busch C, Rehak M, Massin P, Barbosa-Breda J, Lupidi M, Mariotti C, Hamza M, Grise-Dulac A, Gabrielle PH, Baillif S, Creuzot-Garcher C. Intraocular Pressure Changes After Intravitreal Fluocinolone Acetonide Implant: Results from Four European Countries. Ophthalmol Ther. 2022;11(3):1217-1229. doi:10.1007/s40123-022-00504-z
  • Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, Baillif S, Ballotti R, Bertolotto C. Recent advances in understanding the role of HES6 in cancers. Theranostics. 2022;12(9):4374-4385. doi:10.7150/thno.72966
  • Krossa I, Strub T, Aplin AE, Ballotti R, Bertolotto C. Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma? Cancers. 2022;14(19):4865. doi:10.3390/cancers14194865
  • Kodjikian L, Tadayoni R, Souied EH, Baillif S, Milazzo S, Dumas S, Uzzan J, Bernard L, Decullier E, Huot L, Mathis T. EFFICACY AND SAFETY OF AFLIBERCEPT FOR THE TREATMENT OF IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG PATIENTS: The INTUITION Study. Retina Phila Pa. 2022;42(2):290-297. doi:10.1097/IAE.0000000000003310
  • Kodjikian L, Baillif S, Couturier A, Creuzot-Garcher C, Delyfer MN, Matonti F, Weber M. Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: A national Delphi consensus study. Eur J Ophthalmol. 2022;32(5):2845-2856. doi:10.1177/11206721211052852
  • Khatir W, Humbert O, Benzaquen J, Bontoux C, Neels J, Berland L, Rivera FAG, Allegra M, Salah M, Tanga V, Bordone O, Fayada J, Lespinet-Fabre V, Bohly D, Long-Mira E, Lassalle S, Vouret V, Brest P, Mograbi B, Maniel C, Otto J, Boutros J, Heeke S, Hofman V, Marquette CH, Hofman P, Ilié M. Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Clin Transl Med. 2022;12(8):e1018. doi:10.1002/ctm2.1018
  • Ilié M, Hofman V, Bontoux C, Heeke S, Lespinet-Fabre V, Bordone O, Lassalle S, Lalvée S, Tanga V, Allegra M, Salah M, Bohly D, Benzaquen J, Marquette CH, Long-Mira E, Hofman P. Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France). Cancers. 2022;14(9):2258. doi:10.3390/cancers14092258
  • Ilié M, Benzaquen J, Tourniaire P, Heeke S, Ayache N, Delingette H, Long-Mira E, Lassalle S, Hamila M, Fayada J, Otto J, Cohen C, Gomez-Caro A, Berthet JP, Marquette CH, Hofman V, Bontoux C, Hofman P. Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images. Cancers. 2022;14(7):1740. doi:10.3390/cancers14071740
  • Ilié M, Beaulande M, Long-Mira E, Bontoux C, Zahaf K, Lalvée S, Hamila M, Benzaquen J, Cohen C, Berthet JP, Marquette CH, Lassalle S, Hofman V, Hofman P. Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer. Lung Cancer Amst Neth. 2022;166:1-8. doi:10.1016/j.lungcan.2022.01.022
  • Fabre M, Mateo L, Lamaa D, Baillif S, Pagès G, Demange L, Ronco C, Benhida R. Recent Advances in Age-Related Macular Degeneration Therapies. Mol Basel Switz. 2022;27(16):5089. doi:10.3390/molecules27165089
  • Estrada C, Mirabal-Ortega L, Méry L, Dingli F, Besse L, Messaoudi C, Loew D, Pouponnot C, Bertolotto C, Eychène A, Druillennec S. MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells. Commun Biol. 2022;5(1):101. doi:10.1038/s42003-022-03049-w
  • Di Vincenzo H, Kauert A, Martiano D, Chiabo J, Di Vincenzo D, Sozonoff I, Baillif S, Martel A. Efficacy and safety of a standardized hyperbaric oxygen therapy protocol for retinal artery occlusion. Undersea Hyperb Med J Undersea Hyperb Med Soc Inc. 2022;49(4):495-505. doi:10.22462/07.08.2022.9
  • Baillif S, Staccini P, Weber M, Delyfer MN, Le Mer Y, Gualino V, Collot L, Merite PY, Creuzot-Garcher C, Kodjikian L, Massin P. Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant. Pharmaceutics. 2022;14(11):2391. doi:10.3390/pharmaceutics14112391

2021

  • Tran THC, Erginay A, Verdun S, Fourmaux E, Le Rouic JF, Uzzan J, Milazzo S, Baillif S, Kodjikian L. One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema. Clin Ophthalmol Auckl NZ. 2021;15:1971-1978. doi:10.2147/OPTH.S304030
  • Strub T, Martel A, Nahon-Esteve S, Baillif S, Ballotti R, Bertolotto C. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology. Prog Retin Eye Res. 2021;85:100968. doi:10.1016/j.preteyeres.2021.100968
  • Soysouvanh F, Giuliano S, Habel N, El-Hachem N, Pisibon C, Bertolotto C, Ballotti R. An Update on the Role of Ubiquitination in Melanoma Development and Therapies. J Clin Med. 2021;10(5):1133. doi:10.3390/jcm10051133
  • Rimini M, Franco P, De Bari B, Zampino MG, Vagge S, Frassinetti GL, Arcadipane F, Bacigalupo A, Valgiusti M, Aloi D, Gervaso L, Corvò R, Bartolini G, Gerardi MA, Cascinu S, Casadei-Gardini A. The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation. Cancers. 2021;13(4):671. doi:10.3390/cancers13040671
  • Re D, Barrière J, Chamorey E, Delforge M, Gastaud L, Petit E, Chaminade A, Verrière B, Peyrade F. Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies. Leuk Lymphoma. 2021;62(13):3308-3310. doi:10.1080/10428194.2021.1957877
  • Pisibon C, Ouertani A, Bertolotto C, Ballotti R, Cheli Y. Immune Checkpoints in Cancers: From Signaling to the Clinic. Cancers. 2021;13(18):4573. doi:10.3390/cancers13184573
  • Pinto M, Mathis T, Massin P, Akesbi J, Lereuil T, Voirin N, Matonti F, Fajnkuchen F, Conrath J, Milazzo S, Korobelnik JF, Baillif S, Denis P, Creuzot-Garcher C, Srour M, Dupas B, Sudhalkar A, Bilgic A, Tadayoni R, Souied EH, Dot C, Kodjikian L. Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study. Pharmaceutics. 2021;13(2):194. doi:10.3390/pharmaceutics13020194
  • Pautas C, Raffoux E, Lambert J, Legrand O, Chantepie S, Gastaud L, Marolleau JP, Thomas X, Turlure P, Benner RJ, Vandendries E, Gogat K, Dombret H, Castaigne S. Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia. Bone Marrow Transplant. 2021;56(6):1474-1477. doi:10.1038/s41409-020-01207-4
  • Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, Herlyn M, Holmen SL, Karreth FA, Kaufman CK, Khan S, Kobold S, Leucci E, Levy C, Lombard DB, Lund AW, Marie KL, Marine JC, Marais R, McMahon M, Robles-Espinoza CD, Ronai ZA, Samuels Y, Soengas MS, Villanueva J, Weeraratna AT, White RM, Yeh I, Zhu J, Zon LI, Hurlbert MS, Merlino G. Melanoma models for the next generation of therapies. Cancer Cell. 2021;39(5):610-631. doi:10.1016/j.ccell.2021.01.011
  • Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death Differ. 2021;28(6):1990-2000. doi:10.1038/s41418-020-00730-7
  • Nathan P, Hassel JC, Rutkowski P, Baurain JF, Butler MO, Schlaak M, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Joshua AM, Sacco JJ, Shoushtari AN, Orloff M, Piulats JM, Milhem M, Salama AKS, Curti B, Demidov L, Gastaud L, Mauch C, Yushak M, Carvajal RD, Hamid O, Abdullah SE, Holland C, Goodall H, Piperno-Neumann S, IMCgp100-202 Investigators. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2021;385(13):1196-1206. doi:10.1056/NEJMoa2103485
  • Nahon-Esteve S, Martel A, Maschi C, Alketbi M, Baillif S, Tieulie N. Uveitis associated with latent tuberculosis: A comparative study of the impact of antitubercular therapy combined or not with systemic corticosteroids. Eur J Ophthalmol. 2021;31(5):2457-2466. doi:10.1177/1120672120962066
  • Nahon-Estève S, Martel A, Maschi C, Baillif S, Lassalle S, Caujolle JP. Swept-Source and Spectral-Domain OCT Imaging of Conjunctival Tumors. Ophthalmology. 2021;128(6):947-950. doi:10.1016/j.ophtha.2020.09.036
  • Nahon-Estève S, Bertolotto C, Picard-Gauci A, Gastaud L, Baillif S, Hofman P, Groulier A, Maschi C, Caujolle JP, Lassalle S, Martel A. Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives. Cancers. 2021;13(22):5691. doi:10.3390/cancers13225691
  • Montaudié H, Beranger GE, Reinier F, Nottet N, Martin H, Picard-Gauci A, Troin L, Ballotti R, Passeron T. Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma. Pigment Cell Melanoma Res. 2021;34(5):978-983. doi:10.1111/pcmr.12958
  • Monjanel B, Baillif S, Lagier J, Gastaud L, Poissonnet G, Martel A. Efficacy and safety of an artificial dermal graft for the reconstruction of exenterated sockets: a preliminary report. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2021;259(9):2827-2835. doi:10.1007/s00417-021-05155-7
  • Mathis T, Maschi C, Mosci C, Espensen CA, Rosier L, Favard C, Tick S, Remignon CH, Ligorio P, Bonin N, Gambrelle J, Nguyen AM, Faber C, Meyer L, Mouriaux F, Herault J, Baillif S, Kiilgaard JF, Kodjikian L, Caujolle JP, Salleron J, Thariat J. COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA. Retina Phila Pa. 2021;41(2):277-286. doi:10.1097/IAE.0000000000002843
  • Martel A, Lassalle S, Picard-Gauci A, Gastaud L, Montaudie H, Bertolotto C, Nahon-Esteve S, Poissonnet G, Hofman P, Baillif S. New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New “Eye-Sparing” Paradigm? Cancers. 2021;13(11):2822. doi:10.3390/cancers13112822
  • Martel A, Farah E, Zmuda M, Almairac F, Jacomet PV, Galatoire O. Autologous dermis graft versus conchal cartilage graft for managing lower eyelid retraction: A comparative study. Eur J Ophthalmol. 2021;31(4):1733-1740. doi:10.1177/1120672120934408
  • Martel A, Bougaci N, Lagier J, Almairac F, Dagain A. Post-traumatic orbitorrhea: An underestimated life-threatening complication following anterior skull base fractures. Eur J Ophthalmol. 2021;31(2):NP123-NP125. doi:10.1177/1120672119867827
  • Martel A, Baillif S, Thomas P, Almairac F, Galatoire O, Hamedani M, Fontaine D, Lanteri-Minet M. Phantom eye pain: a multicentric study in 100 patients. Acta Ophthalmol (Copenh). 2021;99(5):e753-e760. doi:10.1111/aos.14657
  • Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Lassalle S, Lagier J, Hamedani M, Poissonnet G. Orbital exenteration: an updated review with perspectives. Surv Ophthalmol. 2021;66(5):856-876. doi:10.1016/j.survophthal.2021.01.008
  • Martel A, Nahon-Estève S, Appert Flory A, Lassalle S, Leonardo S, Tieulié N, Caujolle JP. Ligneous conjunctivitis masquerading as a large, recurrent conjunctival tumor. J Fr Ophtalmol. 2021;44(3):451-453. doi:10.1016/j.jfo.2020.04.052
  • Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers. 2021;14(1):96. doi:10.3390/cancers14010096
  • Krossa I, Ballotti R, Bertolotto C. The ERK signaling pathway returns to the limelight in uveal melanomas. Pigment Cell Melanoma Res. 2021;34(5):832-833. doi:10.1111/pcmr.12965
  • Kodjikian L, Lecleire-Collet A, Dot C, Le Lez ML, Baillif S, Erginay A, Souied E, Fourmaux E, Gain P, Ponthieux A. ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema. Clin Ophthalmol Auckl NZ. 2021;15:2307-2315. doi:10.2147/OPTH.S313081
  • Kodjikian L, Baillif S, Creuzot-Garcher C, Delyfer MN, Matonti F, Weber M, Mathis T. Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review. Pharmaceutics. 2021;13(1):72. doi:10.3390/pharmaceutics13010072
  • Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S. Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies. Cell Death Dis. 2021;12(1):64. doi:10.1038/s41419-020-03344-6
  • Jain P, Finger PT, Fili M, Damato B, Coupland SE, Heimann H, Kenawy N, J Brouwer N, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A, American Joint Committee on Cancer Ophthalmic Oncology Task Force. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. Br J Ophthalmol. 2021;105(10):1358-1364. doi:10.1136/bjophthalmol-2020-316293
  • Itzykson R, Fournier E, Berthon C, Röllig C, Braun T, Marceau-Renaut A, Pautas C, Nibourel O, Lemasle E, Micol JB, Adès L, Lebon D, Malfuson JV, Gastaud L, Goursaud L, Raffoux E, Wattebled KJ, Rousselot P, Thomas X, Chantepie S, Cluzeau T, Serve H, Boissel N, Terré C, Celli-Lebras K, Preudhomme C, Thiede C, Dombret H, Gardin C, Duployez N. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021;138(7):507-519. doi:10.1182/blood.2021011103
  • Ilié M, Lantéri E, Chamorey E, Thamphya B, Hamila M, Montaudié H, Picard-Gauci A, Gardrat S, Passeron T, Lassalle S, Long-Mira E, Cherfils-Vicini J, Gilson E, Hofman V, Hofman P. Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma. Oncoimmunology. 2021;10(1):1901446. doi:10.1080/2162402X.2021.1901446
  • Heeke S, Hofman V, Benzaquen J, Otto J, Tanga V, Zahaf K, Allegra M, Long-Mira E, Lassalle S, Marquette CH, Ilie M, Hofman P. Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System. Front Pharmacol. 2021;12:657743. doi:10.3389/fphar.2021.657743
  • Habel N, El-Hachem N, Soysouvanh F, Hadhiri-Bzioueche H, Giuliano S, Nguyen S, Horák P, Gay AS, Debayle D, Nottet N, Béranger G, Paillerets BB de, Bertolotto C, Ballotti R. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. Cell Death Differ. 2021;28(6):1837-1848. doi:10.1038/s41418-020-00710-x
  • Fish AL, Alketbi M, Baillif S. Evaluation of a New Test for the Diagnosis of Congenital Dyschromatopsia in Children: the Color Vision Evaluation Test. Am J Ophthalmol. 2021;223:348-358. doi:10.1016/j.ajo.2020.11.003
  • Espensen CA, Kiilgaard JF, Appelt AL, Fog LS, Herault J, Maschi C, Caujolle JP, Thariat J. Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma. Ophthalmology. 2021;128(1):152-161. doi:10.1016/j.ophtha.2020.06.030
  • Durand N, Simsir M, Signetti L, Labbal F, Ballotti R, Mus-Veteau I. Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells. Mol Basel Switz. 2021;26(7):1867. doi:10.3390/molecules26071867
  • D’Andréa G, Lassalle S, Guevara N, Mograbi B, Hofman P. From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer. Theranostics. 2021;11(3):1310-1325. doi:10.7150/thno.50333
  • Chiabo J, Nahon-Esteve S, Alketbi M, Lassalle S, Tieulie N, Martel A. Orbital non-HIV immune reconstitution inflammatory syndrome after cytapheresis. Eur J Ophthalmol. 2021;31(3):NP85-NP88. doi:10.1177/1120672120919339
  • Chiabo J, Fevrier E, Nahon-Estève S, Ghetemme C, Lagier J, Delas J, Baillif S, Martel A. Incidence of Dacryocystorhinostomy (DCR) in France: A Nationwide Study over the 2010-2019 Period. Ophthalmic Epidemiol. 2021;28(6):526-532. doi:10.1080/09286586.2021.1880605
  • Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R. ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. Mol Cancer. 2021;20(1):12. doi:10.1186/s12943-020-01306-2
  • Charles A, Staccini P, Martel A, Baillif S. Cataract Surgery in One-Eyed Patients: A Cohort Study of 100 Patients. J Ophthalmol. 2021;2021:5581512. doi:10.1155/2021/5581512
  • Bertolotto C. Cutaneous and uveal melanoma: two different cancers in therapeutic needs. C R Biol. 2021;344(3):219-231. doi:10.5802/crbiol.63

2020

 

  • Weber M, Dominguez M, Coscas F, Faure C, Baillif S, Kodjikian L, Cohen SY. Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW. BMC Ophthalmol. 2020;20(1):206. doi:10.1186/s12886-020-01468-z
  • Vandefonteyne S, Caujolle JP, Rosier L, Conrath J, Quentel G, Tadayoni R, Maschi C, Le Mer Y, Dot C, Aknin I, Thariat J, Baillif S. Diagnosis and treatment of peripheral exudative haemorrhagic chorioretinopathy. Br J Ophthalmol. 2020;104(6):874-878. doi:10.1136/bjophthalmol-2018-313307
  • Tanga V, Leroy S, Fayada J, Hamila M, Allegra M, Messaoudi Z, Bonnetaud C, Lespinet V, Bordone O, Washetine K, Griffonnet J, Maniel C, Philibert L, Selva E, Benzaquen J, Ilie M, Long E, Lassalle S, Lantéri E, Marquette CH, Hofman V, Hofman P. Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France). Biopreservation Biobanking. 2020;18(6):517-524. doi:10.1089/bio.2020.0055
  • Signetti L, Elizarov N, Simsir M, Paquet A, Douguet D, Labbal F, Debayle D, Di Giorgio A, Biou V, Girard C, Duca M, Bretillon L, Bertolotto C, Verrier B, Azoulay S, Mus-Veteau I. Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma. Cancers. 2020;12(6):1500. doi:10.3390/cancers12061500
  • Mathis T, Espensen CA, Caujolle JP, Herault J, Fog LS, Maschi C, Kodjikian L, Baillif S, Kiilgaard JF, Thariat J. Ultra-widefield fundus photography for radiation therapy planning of ocular tumours. Acta Ophthalmol (Copenh). 2020;98(2):e191-e196. doi:10.1111/aos.14250
  • Mathis T, Caujolle JP, Thariat J. Choroidal Metastasis From Melanoma Treated by Cyberknife Irradiation. JAMA Ophthalmol. 2020;138(1):e190388. doi:10.1001/jamaophthalmol.2019.0388
  • Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Roméo B, Mograbi B, Lassalle S, Hofman P. Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives. Cancers. 2020;12(11):3284. doi:10.3390/cancers12113284
  • Martel A, Caujolle JP, Baillif S, Maschi C, Lassalle S, Nahon-Esteve S. Mascara deposits in an anophthalmic socket mimicking a conjunctival melanoma. J Fr Ophtalmol. 2020;43(9):e325-e326. doi:10.1016/j.jfo.2019.11.044
  • Marcault C, Venton G, Gastaud L, Mannone L, Rey J, D’Incan E, Saillard C, Charbonnier A, Raynaud S, Vey N, Cluzeau T. Alternative Effective and Safe Induction Regimens for Newly Diagnosed Acute Myeloid Leukemia in Patients With Cardiac Contraindication to Anthracyclines. Clin Lymphoma Myeloma Leuk. 2020;20(2):e76-e81. doi:10.1016/j.clml.2019.11.016
  • Lassalle S, Nahon-Esteve S, Frouin E, Boulagnon-Rombi C, Josselin N, Cassoux N, Barnhill R, Scheller B, Baillif S, Hofman P. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome. Int J Mol Sci. 2020;21(23):9147. doi:10.3390/ijms21239147
  • Lassalle S, Hofman V, Heeke S, Benzaquen J, Long E, Poudenx M, Lantéri E, Boutros J, Tanga V, Zahaf K, Lalvée S, Lespinet V, Bordone O, Félix JM, Bonnetaud C, Marquette C, Ilie M, Hofman P. Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France). Cancers. 2020;12(4):955. doi:10.3390/cancers12040955
  • Hofman V, Benzaquen J, Heeke S, Lassalle S, Poudenx M, Long E, Lantéri E, Bordone O, Lespinet V, Tanga V, Bonnetaud C, Bille Y, Ilié M, Marquette C, Barlesi F, Boutros J, Hofman P. Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France). Lung Cancer Amst Neth. 2020;145:58-62. doi:10.1016/j.lungcan.2020.04.024
  • Heeke S, Benzaquen J, Hofman V, Ilié M, Allegra M, Long-Mira E, Lassalle S, Tanga V, Salacroup C, Bonnetaud C, Fayada J, Gazoppi L, Ribeyre L, Castelnau O, Garnier G, Cattet F, Nanni I, de Fraipont F, Cohen C, Berthet JP, Leroy S, Poudenx M, Marquette CH, Denis MG, Barlesi F, Hofman P. Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France). Clin Lung Cancer. 2020;21(1):56-65.e8. doi:10.1016/j.cllc.2019.07.010
  • Gaudel C, Soysouvanh F, Leclerc J, Bille K, Husser C, Montcriol F, Bertolotto C, Ballotti R. Regulation of Melanogenesis by the Amino Acid Transporter SLC7A5. J Invest Dermatol. 2020;140(11):2253-2259.e4. doi:10.1016/j.jid.2020.03.941
  • Gardin C, Pautas C, Fournier E, Itzykson R, Lemasle E, Bourhis JH, Adès L, Marolleau JP, Malfuson JV, Gastaud L, Raffoux E, Lambert J, Braun T, Thomas X, Chantepie S, Cluzeau T, de Botton S, Berthon C, Boissel N, Duployez N, Terré C, Peffault de Latour R, Michallet M, Celli-Lebras K, Preudhomme C, Dombret H. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood Adv. 2020;4(9):1942-1949. doi:10.1182/bloodadvances.2019001349
  • Fajnkuchen F, Delyfer MN, Conrath J, Baillif S, Mrejen S, Srour M, Bellamy JP, Dupas B, Lecleire-Collet A, Meillon C, Bonicel P, Hobeika M, Giocanti-Aurégan A. Expectations and fears of patients with diabetes and macular edema treated by intravitreal injections. Acta Diabetol. 2020;57(9):1081-1091. doi:10.1007/s00592-020-01513-9
  • El Chehab H, Gatinel D, Baudouin C, Muraine M, Hoffart L, Rozot P, Mehanna C, Bonnet C, Nordmann JP, Santiago PY, Burillon C, Baillif S, Pisella PJ, Weber M, Robinet-Perrin A, Deidier D, Hay A, Villain M, Baïkoff G, Gauthier AS, Mathis T, Dot C. Complications of cosmetic iris implants: French series of 87 eyes. J Cataract Refract Surg. 2020;46(1):34-39. doi:10.1097/j.jcrs.0000000000000032
  • de Parisot A, Jamilloux Y, Kodjikian L, Errera MH, Sedira N, Heron E, Pérard L, Cornut PL, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, André M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Amamra N, Guerre P, Decullier E, Sève P, ULISSE group. Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study). PloS One. 2020;15(2):e0228918. doi:10.1371/journal.pone.0228918
  • Couret C, Poinas A, Volteau C, Riche VP, Le Lez ML, Errera MH, Creuzot-Garcher C, Baillif S, Kodjikian L, Ivan C, Le Jumeau de Kergaradec LM, Chiffoleau A, Jobert A, Jaulin J, Biron L, Hervouet E, Weber M. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial. Trials. 2020;21(1):159. doi:10.1186/s13063-020-4066-0
  • Carle X, Gastaud L, Salleron J, Tardy MP, Caujolle JP, Thyss A, Thariat J, Chevallier P. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres. Bull Cancer (Paris). 2020;107(12):1274-1283. doi:10.1016/j.bulcan.2020.09.010
  • Calleja A, Yun S, Moreilhon C, Karsenti JM, Gastaud L, Mannone L, Komrokji R, Al Ali N, Dadone-Montaudie B, Robert G, Auberger P, Raynaud S, Sallman DA, Cluzeau T. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment. Eur J Haematol. 2020;104(5):488-498. doi:10.1111/ejh.13390
  • Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, Baillif S, Bailly-Maitre B, Gual P, Ballotti R, Bertolotto C. Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells. Cell Death Discov. 2020;6:22. doi:10.1038/s41420-020-0259-2
  • Ballotti R, Cheli Y, Bertolotto C. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Mol Cancer. 2020;19(1):170. doi:10.1186/s12943-020-01290-7

2019

  • Wiedemann GM, Aithal C, Kraechan A, Heise C, Cadilha BL, Zhang J, Duewell P, Ballotti R, Endres S, Bertolotto C, Kobold S. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12(2):350-360. doi:10.1016/j.tranon.2018.10.014
  • Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, Regazzetti C, Beranger GE, Lereverend C, Pons C, Khemis A, Ballotti R, Bertolotto C, Rocchi S, Passeron T. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun. 2019;10(1):2178. doi:10.1038/s41467-019-09963-8
  • Thariat J, Salleron J, Maschi C, Fevrier E, Lassalle S, Gastaud L, Baillif S, Claren A, Baumard F, Herault J, Caujolle JP. Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas. Radiat Oncol Lond Engl. 2019;14(1):239. doi:10.1186/s13014-019-1426-6
  • Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle JP. Management of Invasive Squamous Cell Carcinomas of the Conjunctiva. Am J Ophthalmol. 2019;200:1-9. doi:10.1016/j.ajo.2018.11.024
  • Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J. High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah’s Witnesses patients: a feasible option in the age of hematopoietic growth factors. Leuk Lymphoma. 2019;60(9):2324-2327. doi:10.1080/10428194.2019.1577414
  • Nahon-Esteve S, Martel A, Maschi C, Caujolle JP, Baillif S, Lassalle S, Hofman P. The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice. Curr Mol Med. 2019;19(9):632-664. doi:10.2174/1566524019666190726161044
  • Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts. Am J Ophthalmol. 2019;201:63-71. doi:10.1016/j.ajo.2019.01.025
  • Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, Mosci C, Caujolle JP, Kodjikian L, Thariat J. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019;68:144-176. doi:10.1016/j.preteyeres.2018.09.003
  • Martel A, Oberic A, Moulin A, Zografos L, Hamedani M. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review. Eye Lond Engl. 2019;33(5):767-771. doi:10.1038/s41433-018-0317-7
  • Malissen N, Macagno N, Granjeaud S, Granier C, Moutardier V, Gaudy-Marqueste C, Habel N, Mandavit M, Guillot B, Pasero C, Tartour E, Ballotti R, Grob JJ, Olive D. HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. Oncoimmunology. 2019;8(12):e1665976. doi:10.1080/2162402X.2019.1665976
  • Leclerc J, Garandeau D, Pandiani C, Gaudel C, Bille K, Nottet N, Garcia V, Colosetti P, Pagnotta S, Bahadoran P, Tondeur G, Mograbi B, Dalle S, Caramel J, Levade T, Ballotti R, Andrieu-Abadie N, Bertolotto C. Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells. Oncogene. 2019;38(8):1282-1295. doi:10.1038/s41388-018-0500-0
  • Kenawy N, Kalirai H, Sacco JJ, Lake SL, Heegaard S, Larsen AC, Finger PT, Milman T, Chin K, Mosci C, Lanza F, Moulin A, Schmitt CA, Caujolle JP, Maschi C, Marinkovic M, Taktak AF, Heimann H, Damato BE, Coupland SE. Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome. Pigment Cell Melanoma Res. 2019;32(4):564-575. doi:10.1111/pcmr.12767
  • Jouhi S, Jager MJ, de Geus SJR, Desjardins L, Eide NA, Grange JD, Kiilgaard JF, Seregard S, Midena E, Parrozzani R, Caujolle JP, Rospond-Kubiak I, Kivelä TT. The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group. Am J Ophthalmol. 2019;202:100-108. doi:10.1016/j.ajo.2019.01.031
  • Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A, American Joint Committee on Cancer Ophthalmic Oncology Task Force. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol. 2019;137(8):905-911. doi:10.1001/jamaophthalmol.2019.1640
  • Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P. Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2019;14(7):1204-1212. doi:10.1016/j.jtho.2019.03.024
  • Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M. Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time? Cancers. 2019;11(3):283. doi:10.3390/cancers11030283
  • Garandeau D, Noujarède J, Leclerc J, Imbert C, Garcia V, Bats ML, Rambow F, Gilhodes J, Filleron T, Meyer N, Brayer S, Arcucci S, Tartare-Deckert S, Ségui B, Marine JC, Levade T, Bertolotto C, Andrieu-Abadie N. Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Mol Cancer Ther. 2019;18(2):289-300. doi:10.1158/1535-7163.MCT-17-1141
  • Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell’Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P. Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier). Cancer Manag Res. 2019;11:3631-3642. doi:10.2147/CMAR.S197349
  • Boulahssass R, Gonfrier S, Champigny N, Lassalle S, François E, Hofman P, Guerin O. The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience. Cancers. 2019;11(2):192. doi:10.3390/cancers11020192
  • Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC. Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses. Cell Rep. 2019;29(3):573-588.e7. doi:10.1016/j.celrep.2019.09.009
  • Berland L, Heeke S, Humbert O, Macocco A, Long-Mira E, Lassalle S, Lespinet-Fabre V, Lalvée S, Bordone O, Cohen C, Leroy S, Hofman V, Hofman P, Ilié M. Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors. J Thorac Dis. 2019;11(Suppl 1):S71-S80. doi:10.21037/jtd.2018.11.102

Dernière révision : 11/05/2023

Faire un don

Soutenez-nous dans nos combats contre les cancers oculaires !

Le Département d’Onco-Ophtalmologie Niçois (DOON) dispose d’un Fonds de dotation destiné à recevoir des dons. Les fonds sont utilisés pour le financement de projets scientifiques et médicaux de recherche, des projets d’éducation thérapeutique pour les patients ou des projets visant à améliorer de la qualité de vie des patients présentant une tumeur oculaire.

Nous utilisons des cookies pour vous offrir la meilleure expérience possible. Vous pouvez en savoir plus sur les cookies que nous utilisons ou les désactiver dans les paramètres de confidentialité.
AccepterParamètres de confidentialité

RGPD

  • Gestion des cookies

Gestion des cookies

Ce site web utilise des traceurs visant à générer des statistiques de fréquentation lors de votre navigation sur le site. Aucune donnée n’est partagé auprès de tiers. En savoir plus sur la politique de confidentialité du DOON. j

You may choose to prevent this website from aggregating and analyzing the actions you take here. Doing so will protect your privacy, but will also prevent the owner from learning from your actions and creating a better experience for you and other users.